Wormiza 222 mg tablets contain Fenbendazole, an anthelmintic (deworming) medication. This product is generally a veterinary-grade medication used to treat a wide range of gastrointestinal parasites in animals such as dogs, cats, and livestock. Key Details
- Active Ingredient: Fenbendazole.
- Primary Use (Veterinary): Treats infections caused by roundworms, hookworms, lungworms, whipworms, and some tapeworms in animals.
Important Considerations for Human UseWhile the product is advertised by some sellers in India for human use, Fenbendazole is not approved for human consumption by major regulatory bodies like the U.S. FDA or the European Medicines Agency (EMA).
- Unapproved for Humans: Scientific data regarding its safety and efficacy in humans for general use is limited.
- Off-Label/Alternative Use: It has gained attention in alternative and self-medication circles for potential anti-cancer properties, but this remains unproven in robust human clinical trials and is highly discouraged without medical supervision.
- Approved Alternatives: For human parasitic infections, doctors typically prescribe approved medications from the same drug family, such as Albendazole or Mebendazole.
- Safety Risks: Self-administration can be unsafe and has been associated with potential side effects, including liver damage, in some case reports.
Warnings and Side EffectsIf used under a doctor's advice (in regions where this is allowed for specific conditions), potential side effects and precautions include:
- Side Effects: Nausea, diarrhea, dizziness, headaches, and abdominal pain are possible.
- Pregnancy: It is considered potentially harmful during pregnancy and should be avoided.
- Medical Supervision: Regular monitoring of blood counts and liver function may be necessary during treatment.